Latest 30 News in the Life Sciences Industry
GlobeNewswire
Memo Therapeutics AG Presents Further Analyses of the Phase II Trial Results of Potravitug for the Treatment of BKPyV Infection in Kidney Transplant Recipients in an Oral Presentation at the 63rd European Renal Association Congress
05 Jun 2026
PR Newswire Association LLC.
Micro Imaging Technology is pleased to Announce the Acquisition of Cellmyx
05 Jun 2026
GlobeNewswire
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
04 Jun 2026
PR Newswire Association LLC.
CeQur® Announces Exciting Advancements: 2 Recent FDA Clearances and New Clinical Evidence to be Presented at ADA
04 Jun 2026
GlobeNewswire
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
03 Jun 2026
PR Newswire Association LLC.
ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
03 Jun 2026
GlobeNewswire
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
03 Jun 2026
PR Newswire Association LLC.
NIANCE Expands Beyond Products into a Global Beauty & Longevity Ecosystem
03 Jun 2026
GlobeNewswire
Xcube.bio Strengthens Board with Appointment of Three Distinguished Non-Executive Directors
03 Jun 2026
GlobeNewswire
Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea
02 Jun 2026
GlobeNewswire
Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies
02 Jun 2026
GlobeNewswire
Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
02 Jun 2026
GlobeNewswire
FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting
02 Jun 2026
GlobeNewswire
Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML
01 Jun 2026
GlobeNewswire
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
01 Jun 2026
GlobeNewswire
New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension
01 Jun 2026
PR Newswire Association LLC.
Driving Innovation, Empowering Partners: ACROBiosystems Showcases Comprehensive CGT Solutions Anchored by GMP Capabilities at Bio Korea 2026
01 Jun 2026
GlobeNewswire
Roche to present new data advancing its obesity portfolio at the American Diabetes Association’s 2026 Scientific Sessions
01 Jun 2026
PR Newswire Association LLC.
Newel Health and Gerresheimer Launch Strategic Collaboration to Support Pharma Companies in the Era of Integrated Digital Therapies
27 May 2026
PR Newswire Association LLC.
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
27 May 2026
PR Newswire Association LLC.
ABILITY Neurotech Receives IMDD Approval to Start Clinical Trial for Chronic Implantation of Brain-Computer Interface in ALS Patients
26 May 2026
PR Newswire Association LLC.
Implantica publishes Interim Report January - March 2026 (Q1)
22 May 2026
PR Newswire Association LLC.
Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan
22 May 2026
PR Newswire Association LLC.
Implantica announces publication of a new health economics study showing RefluxStop®'s superior cost-effectiveness in the treatment of GERD in the Italian Healthcare System
21 May 2026
PR Newswire Association LLC.
Implantica submits final response to FDA in the PMA application for RefluxStop® for U.S. market approval
20 May 2026
Upcoming Events All Events
- June 2026
- San Diego: RESI San Diego 2026
- San Diego: BIO 2026
- July 2026
- Taipei: BIO Asia-Taiwan